Lee Yingshan, Tan Leon Yuan Rui, Ho Yong Howe, Leow Melvin Khee Shing
Department of Endocrinology, Tan Tock Seng Hospital, Singapore, Asia.
Lee Kong Chian School of Medicine, Singapore, Asia.
BMJ Case Rep. 2017 Nov 3;2017:bcr-2017-222553. doi: 10.1136/bcr-2017-222553.
Neurofibromatosis type 1 (NF1) is a multisystem genetic disorder associated with reduced lifespan attributed largely to malignancy and vascular causes. One of the tumours associated with NF1 is phaeochromocytoma. The phaeochromocytoma has earned the moniker, a 'great mimicker', due to its varied means of presentation. We present a patient with NF1 who was diagnosed with a giant 20 cm phaeochromocytoma after suffering from an ischaemic stroke. Current guidelines do not advocate surveillance of phaeochromocytoma in asymptomatic patients with NF1, unlike other genetic syndromes associated with phaeochromocytoma. However, there is increasing evidence that this approach may not help in the early detection and treatment of this potentially life-threatening disease. Our patient remained hypertensive after surgery despite achieving biochemical cure. The suggested chronicity of the underlying tumour in our patient is a reminder to practising clinicians to rethink our strategy in identifying phaeochromocytoma in adults with NF1.
1型神经纤维瘤病(NF1)是一种多系统遗传性疾病,其寿命缩短主要归因于恶性肿瘤和血管性病因。与NF1相关的肿瘤之一是嗜铬细胞瘤。嗜铬细胞瘤因其多样的表现方式而获得了“伟大模仿者”这一称号。我们报告一名患有NF1的患者,该患者在发生缺血性中风后被诊断出患有一个20厘米的巨大嗜铬细胞瘤。与其他与嗜铬细胞瘤相关的遗传综合征不同,目前的指南不主张对无症状的NF1患者进行嗜铬细胞瘤监测。然而,越来越多的证据表明,这种方法可能无助于早期发现和治疗这种潜在的危及生命的疾病。尽管手术实现了生化治愈,但我们的患者术后仍有高血压。我们患者潜在肿瘤的推测慢性病程提醒临床医生重新思考我们在识别成年NF1患者嗜铬细胞瘤方面的策略。